Cresco Labs Earnings + Call Notes
U.S. cannabis leader shares Q323 results.
$191M Revs; est. $184M
$49M AEBITDA; est. $38.6M
$94M GP; est. $88.3M
51% GM; est. 48.1%
($113mm) NI; est. ($17.7m)
$41M OCF+ [inclusive of $8M 1X charge]
Call Notes
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.